Recombinant Human NECTIN4 Protein，His

NECTIN4, a member of the nectin family of cell adhesion molecules, has garnered significant attention in recent years due to its role in various biological processes and potential implications in cancer biology. It is primarily expressed in epithelial tissues and is involved in cell-cell adhesion, influencing cellular signaling pathways critical for tumor progression and metastasis. Elevated levels of NECTIN4 have been observed in several malignancies, including breast and ovarian cancers, where it is associated with poor prognosis and increased metastatic potential. This has led researchers to investigate NECTIN4 as a potential therapeutic target, particularly for developing monoclonal antibodies or targeted therapies aimed at inhibiting its function. Additionally, NECTIN4's involvement in immune evasion mechanisms has prompted exploration of its role in modulating the tumor microenvironment and its potential as a biomarker for immune checkpoint therapy responses. As a result, the study of NECTIN4 recombinant proteins has become pivotal in elucidating its biological functions and therapeutic applications, paving the way for innovative strategies in cancer treatment and management. Researchers are focusing on characterizing the structural properties of the recombinant NECTIN4 protein to understand its interactions with ligands and receptors, thereby enhancing the development of targeted interventions to disrupt its pathological roles in cancer.